Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female age ≤ 37 years~* BMI 18-29 kg/m2~* Regular cycle (25-35 days)~* Standard indication for IVF~* No major uterine abnormalities~* Written informed consent~Exclusion Criteria:~* Indication for IVF male factor with a total motile sperm count \< 20x106~* ICSI or andrological indication~* Known abnormal (male or female) karyotype~* Oocyte donation~* One previous IVF treatment not resulting in embryo transfer~* History of recurrent abortion~* Medical contra indication for pregnancy or IVF treatment~* Relevant systemic disease~* Active substance abuse

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 37 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Conventional regimen with a daily dose of 225 IU recombinant FSH and GnRH agonist long protocol co-treatment.
- 2 (Type: EXPERIMENTAL): Mild ovarian stimulation regimen using the endogenous FSH production by starting treatment on day 5 of the menstrual cycle with 150 IU / d recFSH with GnRH antagonist co treatment starting on day 6. As soon as two follicles reach 12 mm, treatment is continued with 200 IU / d rec hCG.

Based on this trial design, predict the completion outcome and termination type (if applicable).